Hepatitis B virus X protein (pX) is implicated in hepatocellular carcinoma pathogenesis by an unknown mechanism. Employing the tetracycline-regulated pX-expressing 4pX-1 cell line, derived from the murine AML12 hepatocyte cell line, we demonstrate that pX induces partial polyploidy (>4N DNA). Depletion of p53 in 4pX-1 cells increases by 5-fold the polyploid cells in response to pX expression, indicating that p53 antagonizes pX-induced polyploidy. Dual-parameter flow cytometric analyses show pX-dependent bromodeoxyuridine (BrdUrd) incorporation in 4pX-1 cells containing 4N and >4N DNA, suggesting pX induces DNA re-replication. Interestingly, pX increases expression of endogenous replication initiation factors Cdc6 and Cdtl while suppressing geminin expression, a negative regulator of rereplication. In comparison to a geminin knockdown 4pX-1 cell line used as DNA re-replication control, the Cdt1/geminin ratio is greater in 4pX-1 cells expressing pX, indicating that pX promotes DNA re-replication. In support of this conclusion, pX-expressing 4pX-1 cells, similar to the geminin knockdown 4pX-1 cells, continue to incorporate BrdUrd in the G 2 phase and exhibit nuclear Cdc6 and MCM5 co-localization and the absence of geminin. In addition, pX expression activates the ATR kinase, the sensor of DNA re-replication, which in turn phosphorylates RAD17 and H2AX. Interestingly, phospho-H2AX-positive and BrdUrd -positive cells progress through mitosis, demonstrating a link between pX-induced DNA re-replication and polyploidy. Our studies highlight a novel function of pX that likely contributes to hepatocellular carcinoma pathogenesis. Chronic hepatitis B virus (HBV)4 infection results in the development of hepatocellular carcinoma (HCC) by the fourth or fifth decade (1) by an unknown mechanism. In HBV-mediated HCC the rate of chromosomal aberrations is significantly increased in comparison to HCC associated with other risk factors (2-4). However, the mechanism by which genomic changes initiate HCC development is not yet understood (5-7). Herein, employing the HBV X protein (pX) as the oncogenic signal, we investigate whether pX expression induces chromosomal abnormalities, resulting in HCC pathogenesis.The link between HBV-mediated HCC and pX is derived both from clinical evidence (8) as well as animal and cell culture transformation studies (9). Specifically, integration of HBV DNA into the host genome occurs at early steps of clonal tumor expansion, with most tumors displaying sustained expression of pX (8). Importantly, pX, which is essential for the viral life cycle (10), is a multifunctional protein inducing activation of the cellular mitogenic ras-raf-MAPK, c-Jun NH 2 -terminal kinase, and p38MAPK pathways (11) and transcription of select viral and cellular genes (9). These pX activities deregulate cellular gene expression, resulting either in unscheduled cell cycle progression (12) or apoptosis (13), depending on the growth conditions. Specifically, pX expression sensitizes the less-differentiated 4pX-1 hepatocyte cell ...
Chronic Hepatitis B virus (HBV) infection is linked to development of hepatocellular carcinoma (HCC). The HBV X protein (pX) is implicated in HCC pathogenesis acting as a weak oncogene or a co-factor in hepatocarcinogenesis. pX induces DNA re-replication, DNA damage and partial polyploidy in a poorly differentiated, immortalized hepatocyte cell line. In this study, we employed sorted, pX-induced polyploid cells to investigate their growth and oncogenic transformation potential, over the course of 70 cell doublings. Immediately after live cell-sorting, nearly 40% of pX-induced polyploid cells undergo apoptosis, while the surviving cells exhibit proliferation sensitive to p53. After 40 cell generations, the pX-expressing polyploid cultures exhibit loss of p53 function and become growth factor-and anchorage-independent, indicative of oncogenic transformation. The pX-induced polyploid cultures in the course of 70 cell generations undergo progressively increasing DNA damage, propagate damaged DNA to daughter cells, and display increased expression of a cluster of proliferation genes shown to be elevated in human HCC, including HBV-HCC. One of these genes is the mitotic kinase Polo-like kinase 1 (Plk1). Oncogenic transformation is suppressed in the absence of pX expression, and significantly, by inhibition of Plk1. These results identify Plk1 as crucial in pX-mediated oncogenic transformation.Conclusion-Partial polyploidy induced by pX is not immediately associated with oncogenic transformation. Continued DNA damage for 40 cell generations is reproducibly associated with loss of p53 function, enhanced expression of Plk1 and oncogenic transformation. Since Plk1 expression is also elevated in HBV-HCC tumors, this in vitro cellular model simulates liver cancer progression and pathogenesis in chronic HBV patients. Inhibition of Plk1 activity suppresses pXmediated oncogenic transformation, identifying Plk1 as a promising therapeutic target for HBVmediated HCC. KeywordsHepatitis B Virus X protein; hepatocellular carcinoma; polyploidy; DNA damage; oncogenic transformation; p53; polo-like kinase1 (Plk1); BubR1 [3][4][5], that defective DNA repair causes chromosomal instability, accelerating liver carcinogenesis (6), and genomic instability is likely the primary cause of carcinogenesis, based on the slow kinetics from carcinogen exposure to cancer development (7).The mechanism of HCC pathogenesis by chronic HBV infection involves effects of chronic inflammation and regeneration of the liver (8), and effects of two HBV proteins, the X (9) and S (10) proteins. HBV DNA integrates into the host genome during early steps of tumor expansion (11), and most tumors continue to express the X protein (pX). pX is multifunctional, essential for the viral life cycle (12), and implicated in HCC pathogenesis (9,11), acting as a weak oncogene (13) or a co-factor in hepatocarcinogenesis (14). pX increases the activity of the cellular mitogenic pathways (15) . This cluster includes replication factors MCM4-6, PCNA, Thymidilate Synthase...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.